5FR Stock Chart & Stats
€8.60
€0.15(1.78%)
At close: 4:00 PM EDT
€8.60
€0.15(1.78%)
Day’s Range― - ―
52-Week Range€6.15 - €10.90
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€725.31M
Enterprise Value€171.31K
Total Cash (Recent Filing)€34.07B
Total Debt (Recent Filing)€81.55B
Price to Earnings (P/E)17.9
Beta0.47
Next Earnings
Nov 16, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)96.34
Shares Outstanding76,771,484
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio3.13
Price to Book (P/B)1.34
Price to Sales (P/S)1.01
P/FCF Ratio-37.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€13.44Price Target Upside56.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.51
Revenue Forecast (FY)€715.59M
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthRevenue increased from 86.2B in 2021 to 125.6B in 2026, demonstrating durable expansion in the company’s top line. Although recent growth slowed, the multi-year trajectory supports continued scale, broader product commercialization, and a stronger base for future earnings.
Strong Gross MarginsStable gross margins around 52–54% indicate that Menicon retains attractive economics in its contact-lens and eye-care portfolio. This gross-profit buffer can support investment in products and distribution while helping the business absorb cost pressure over the medium term.
Growing Equity BaseThe equity base has expanded materially from 60.9B to 95.0B between 2021 and 2026, providing a stronger capital foundation for ongoing operations and investment. This growth offers meaningful balance-sheet support even as leverage and returns require monitoring.
Bears Say
Weak Free Cash FlowRecurring negative free cash flow indicates that investment needs or working-capital movements are consuming more cash than the business generates after operating requirements. This reduces financial resilience, limits internally funded growth, and can increase reliance on external capital.
Rising Leverage And Lower ROEHigher debt relative to equity reduces financial flexibility and leaves less room to manage setbacks or fund expansion without additional borrowing. The decline in ROE to about 6.2% also suggests that the growing capital base is currently being used less efficiently.
Profitability CompressionThe decline in net margin from roughly 6.7% to 4.7%, alongside slower recent revenue growth, shows that strong gross economics have not fully translated into sustained bottom-line expansion. Continued pressure below gross profit could constrain earnings compounding and investment capacity.
Menicon Co News
5FR FAQ
What was Menicon Co Ltd’s price range in the past 12 months?
Menicon Co Ltd lowest stock price was €6.15 and its highest was €10.90 in the past 12 months.
What is Menicon Co Ltd’s market cap?
Menicon Co Ltd’s market cap is €725.31M.
When is Menicon Co Ltd’s upcoming earnings report date?
Menicon Co Ltd’s upcoming earnings report date is Nov 16, 2026 which is in 61 days.
How were Menicon Co Ltd’s earnings last quarter?
Menicon Co Ltd released its earnings results on Aug 07, 2026. The company reported €0.162 earnings per share for the quarter, beating the consensus estimate of €0.086 by €0.076.
Is Menicon Co Ltd overvalued?
According to Wall Street analysts Menicon Co Ltd’s price is currently Undervalued.
Does Menicon Co Ltd pay dividends?
Menicon Co Ltd does not currently pay dividends.
What is Menicon Co Ltd’s EPS estimate?
Menicon Co Ltd’s EPS estimate is 0.13.
How many shares outstanding does Menicon Co Ltd have?
Menicon Co Ltd has 76,771,484 shares outstanding.
What happened to Menicon Co Ltd’s price movement after its last earnings report?
Menicon Co Ltd reported an EPS of €0.162 in its last earnings report, beating expectations of €0.086. Following the earnings report the stock price went up 4.808%.
Which hedge fund is a major shareholder of Menicon Co Ltd?
Currently, no hedge funds are holding shares in DE:5FR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Menicon Co Ltd
Menicon Co., Ltd. is a company dedicated to the manufacturing and global distribution of contact lenses and their essential care solutions. The firm supplies its range of eye care products to a diverse network of outlets, including medical facilities like hospitals and ophthalmology clinics, as well as retail channels such as specialized contact lens stores, eyewear retailers, and pharmacies. With a substantial international presence, Menicon extends its reach to over 80 countries, encompassing major markets in the United States, Europe, Oceania, and Asia. This Japanese entity, which was founded in 1943, is based in Nagoya.
5FR Stock 12 Month Forecast
Average Price Target
€13.44
▲(56.22% Upside)
Technical Analysis
HOYA
―
JINS HOLDINGS
―
Japan Eyewear Holdings Co.,Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―